Ann Dermatol.
2009 Nov;21(4):419-422. 10.5021/ad.2009.21.4.419.
A Case of Erythroplasia of Queyrat Treated with Imiquimod 5% Cream and Excision
- Affiliations
-
- 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. khcho@snu.ac.kr
- KMID: 2156511
- DOI: http://doi.org/10.5021/ad.2009.21.4.419
Abstract
- Imiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cryosurgery and applying various kinds of topical agents. We now report a case of typical erythroplasia of Queyrat on glans penis associated with human papillomavirus type 16 infection that was treated by imiquimod 5% cream and the subsequent excision of an imiquimod-resistant penile lesion.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Erythroplasia of Queyrat Treated with Topical 5% 5-Fluorouracil Cream
- Treatment of Erythroplasia of Queyrat with Topical 5 % 5 - Fluorouracil Cream under Occlusion
- Erythroplasia of Queyrat Involving the Distal Glans Penis Surrounding the Urethral Meatus
- Treatment of Keratoacanthoma with 5% Imiquimod Cream
- A Case of Verrucous Carcinoma Treated by 5% Imiquimod Cream
